Abbott's About Face: What It Means for the Physician's Office Market
Executive SummaryIn supplementing its small group practice diagnostics marketing effort with Physician Sales & Service, an outside distributor, Abbott is responding to a tougher business environment. The breadth and exclusivity of the Abbott/PS&S deal is galvanizing competitors to re-think their distributor/manufacturer relationships.
You may also be interested in...
By merging to create Viatris, Mylan and Pfizer’s Upjohn unit intend to occupy a space between generics players and big pharma by offering a broad array of affordable products all around the world.
Progress is being made towards the implementation of the EU’s new patent system, but the UK’s insistence on severing all ties with the European Court could spell the end for its participation.
A year into his role as a CEO of the Belgian mRNA biotech eTheRNA immunotherapies, industry veteran Steven Powell talks to In Vivo about his plans for the business over the coming couple of years. An important timeframe to move the company well into clinical activity.